| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |